RxDoctor Payments Data

Scott Coven

Pediatric Hematology-Oncology · Indianapolis, INNPI 1265728695

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,200 of the $4,276 with a category attached, or 98.2%. Day One Biopharmaceuticals accounts for 99.5% of it on its own, with 1 other manufacturer making up the rest.

$4,276in general payments, 2019–2025

Across 5 payments — averaging $855.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Day One Biopharmaceuticals$4K
  • Jazz Pharmaceuticals Inc.$22
$562,855in research payments, 2019–2025

Across 21 payments — averaging $26,803 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$349K
  • Day One Biopharmaceuticals$93K
  • Jazz Pharmaceuticals Inc.$67K
  • Eli Lilly$54K

What the payments were for

  • Consulting fees$4,20098%
  • Food & beverage$762%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,276 in reported general payments places this provider in the 85th percentile of 59 pediatric hematology-oncology providers in Indiana.

See all pediatric hematology-oncology providers in Indiana

Other pediatric hematology-oncology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →